The Board has decided to remand the case due to a need for a new medical opinion and completion of TERA memorandum. The Veteran's service connection claim for seborrheic dermatitis is being reconsidered.
The deciding factor: The decision was remanded based on the need for a new medical opinion and completion of TERA memorandum, which involves toxic exposure risk activities (TERA).
- Claimed conditions
- seborrheic dermatitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 28, 2023
- Citation
- 23062794
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 23062794.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for service connection for alopecia areata or alopecia androgenic, pseudofolliculitis barbae, and seborrheic dermatitis due to a need for additional evidence.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
- Remanded (sent back)
The Board remands the matter for further development to ensure compliance with previous remand instructions, specifically regarding obtaining a medical opinion from an appropriate specialist and notifying the Veteran about the unavailability of his separation examination.
- Partly granted
The Board granted an initial 30 percent rating for migraine headaches prior to December 5, 2016, and a 50 percent rating from May 31, 2024. The claims for increased ratings for Raynaud's syndrome and seborrheic dermatitis were denied.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.